Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Practical Radiation Oncology|October 29, 2021
Outcomes and Patterns of Recurrence for Anaplastic Thyroid Cancer Treated With Comprehensive ChemoradiotherapyRobert W Gao, Robert L Foote, Yolanda I Garces, et al.
The Lancet. Oncology|September 21, 2010
Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium studyKeith C Bible, Vera J Suman, Julian R Molina, et al.
Thyroid : Official Journal of the American Thyroid Association|November 29, 2018
European Perspective on 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: Proceedings of an Interactive International SymposiumMarkus Luster, Cumali Aktolun, Isabel Amendoeira, et al.
Gynecologic Oncology|June 6, 2012
A phase 2 trial of flavopiridol (Alvocidib) and cisplatin in platin-resistant ovarian and primary peritoneal carcinoma: MC0261Keith C Bible, Prema P Peethambaram, Ann L Oberg, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2012
A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancerKeith C Bible, Vera J Suman, Michael E Menefee, et al.
Thyroid : Official Journal of the American Thyroid Association|October 10, 2019
A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid CancerAshish V Chintakuntlawar, Jun Yin, Robert L Foote, et al.
The Lancet. Oncology|January 21, 2023
Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trialEric J Sherman, Jonathan Harris, Keith C Bible, et al.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2017
Survival in Response to Multimodal Therapy in Anaplastic Thyroid CancerNaiyarat Prasongsook, Aditi Kumar, Ashish V Chintakuntlawar, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 2014
A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057HKeith C Bible, Vera J Suman, Julian R Molina, et al.
The American Journal of Managed Care|June 15, 2012
Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancersKeith C Bible, Robert C Smallridge, John C Morris, et al.
Pageof 6